TMCnet - World's Largest Communications and Technology Community



Hot Stock: Keryx Biopharmaceuticals, Shares Drop 7.6% (KERX)
[December 21, 2012]

Hot Stock: Keryx Biopharmaceuticals, Shares Drop 7.6% (KERX)

Dec 21, 2012 (SmarTrend(R) Spotlight via COMTEX) -- Keryx Biopharmaceuticals (NASDAQ:KERX) is one of today's worst performing low-priced stocks, down 7.6% to $2.56 on 1.4x average daily volume. Thus far today, Keryx Biopharmaceuticals has traded 1.5 million shares, vs. average volume of 1.0 million shares per day. The stock has underperformed the Dow (-7.6% to the Dow's -1.3%) and underperformed the S&P 500 (-7.6% to the S&P's -1.4%) during today's trading.

In the past 52 weeks, shares of Keryx Biopharmaceuticals have traded between a low of $1.28 and a high of $5.55 and are now at $2.56, which is 100% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.4% while the 50-day MA has remained constant.

Keryx Biopharmaceuticals has overhead space with shares priced $2.56, or 41.5% below the average consensus analyst price target of $4.38. Keryx Biopharmaceuticals shares should encounter resistance at the 50-day moving average (MA) of $2.73 and support at its 200-day MA of $2.38.

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development, and commercialization of novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer. Keryx is developing KRX-101 (sulodexide), a novel first-in-class oral heparinold compound for the treatment of diabetic nephropathy.

SmarTrend recommended that subscribers consider buying shares of Keryx Biopharmaceuticals on April 24th, 2012 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $1.83. Since that recommendation, shares of Keryx Biopharmaceuticals have risen 51.4%. We continue to monitor KERX for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Write to Chip Brian at --------------------------------------------------------------------------------------------- SmarTrend analyzes over 5,000 securities simultaneously throughout the trading day and provides its subscribers with trend change alerts in real time. To get a free trial of our trading calls and maximize your trading results, please visit Get exclusive, actionable insight into how the market is expected to trend prior to market open with our free morning newsletter. Sign up at:

[ Back To's Homepage ]

Technology Marketing Corporation

35 Nutmeg Drive Suite 340, Trumbull, Connecticut 06611 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments:
Comments about this site:


© 2018 Technology Marketing Corporation. All rights reserved | Privacy Policy